secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2026-10-13T12:53:18+00:00
Accession:  0000313616-26-000193
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Danaher adds ex-CFO Comas and ex-HilleVax CEO Hershberg to board; Rales brothers waive 500K-share RSUs
--------------------------------------------------------------------------------

- Board expanded to 13 members effective Oct 9, 2026 with appointments of Daniel L. Comas and Robert M. Hershberg, M.D., Ph.D., both serving until the next annual meeting.
- Comas, 62, was Danaher EVP from 2005-2020 and CFO from 2005-2018; he earned $525,000 in 2025 and $393,750 in 2026 as a consultant before that agreement ended Sept 30, 2026.
- Hershberg, 63, was President/CEO/Chairman of HilleVax and an EVP/Chief Scientific Officer at Celgene; he joins the Science and Technology Committee.
- Steven M. Rales and Mitchell P. Rales each waived their 500,000-share Founder RSU awards for no consideration on Oct 9, 2026; the grants were made Aug 4, 2026.
- Director Alan G. Spoon will retire and not stand for re-election at the 2027 annual meeting; the company said it was not due to any disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361626000193/0000313616-26-000193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361626000193/dhr-20261009.htm
  HTML page:      https://secwatch.observer/filing/0000313616-26-000193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer